NASDAQ:FRLN

Freeline Therapeutics Holdings plc Earning Date

USA |NASDAQ |USD

FRLN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Sep 30, 2021 - $-1.12 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Sep 30, 2021 - $0.00 -

FRLN Earnings Date & History Chart

FRLN Earnings & Revenue Forecast

FRLN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.78 $-1.02 $-0.54
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-3.69 $-4.19 $-2.90
Dec 2022 9 $-3.07 $-4.06 $-1.89

FRLN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.96 $-0.96 $-0.96
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.88 $-3.88 $-3.88
Dec 2022 0 / 0 $-3.77 $-3.77 $-3.77

FRLN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $0.00 $0.00 $0.00
Dec 2022 8 $0.00 $0.00 $0.00

FRLN Earnings Date & Revenue History

FRLN Earnings History

|
Show More
Show More

FRLN Revenue History

|
Show More
Show More

Freeline Therapeutics Holdings Plc Next Earnings Date & Report

FRLN Aug 2021 (FQ) Earnings Date & Report Preview

Freeline Therapeutics Holdings Plc Previous Earnings Dates & Reports

FRLN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Freeline Therapeutics Holdings Plc's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

FRLN's earnings per share (EPS) was $-1.12, missing the consensus analysts forecast of $-0.93 by -20.30%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 14.29%.

Revenues were $0.00.

The company reported a net income of $-39.87M.

Free cash flow for the quarter was $-33.74M , compared to $-36.50M last quarter and $-12.78M a year before.

FRLN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Freeline Therapeutics Holdings Plc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

FRLN's earnings per share (EPS) was $-0.88.

Revenues were $0.00.

The company reported a net income of $-96.32M.

Freeline Therapeutics Holdings Plc reported a free cash flow of $-97.48M for its fiscal year, compared to $-55.34M a year ago.